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1. Introduction 
Since the second half of the last century, epidemiology has made key contributions to the 
identification of the causes of common chronic diseases, from cancers to cardiovascular and 
respiratory diseases, paving the way to effective prevention measures. In the process 
sophisticated epidemiologic methodologies have been developed for both observational and 
interventional studies in humans that have become the basis of “evidence-based” medicine 
and public health. 
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Two major developments have changed the scientific and societal contexts in which 
epidemiology operates: the extraordinary advances in molecular genetics, cell and 
developmental biology and a shift towards social philosophies in which individual values 
largely dominate over collective values. These developments affect on one side the aims, 
methods and contents of epidemiology as a research approach to health and disease and on 
the other side the public health perspective that confers a practical value to epidemiology.  
Within this frame, a growing number of young epidemiologists, whose professional life will 
project over the next thirty or forty years, are involved in research, as indicated by the 
increasing number of epidemiology publications in the peer-reviewed literature. Less visible 
are, however, their activities concerning the medium and long term orientation and 
evolution of epidemiology, its role within public health and medicine and, ultimately, its 
ability to make a real difference to population health. 
European Young Epidemiologists (EYE) is a network of young epidemiologists within the 
International Epidemiological Association – European Epidemiology Federation (IEA-EEF), 
founded in 2004, after the European Congress of Epidemiology. EYE aims to establish 
contact among young epidemiologists in Europe in order to facilitate future collaboration in 
scientific research, to engage in the development of epidemiological research methods, to 
foster the appropriate use of epidemiological research in the domains of public health and 
clinical medicine, and mainly to discuss and intervene in the future of epidemiologic 
research. 
In 2011, a worldwide group of Early Career Researchers (ECR group) emerged within the 
International Epidemiological Association with representatives from all continents, and the 
chairman of EYE is the European representative at the worldwide group. This initiative 
reflects the felt need to network, promoting the discussion on what the future of 
epidemiology is and what it should be, by putting emerging epidemiologists’ voices on the 
map about how to make health research work towards scientific and societal development, 
ultimately contributing to improve populations’ health. 
In this context, it seemed timely to us to share this chapter, which summarizes major topics 
that emerged from a 3-day workshop held in Turin, Italy, in 2008, to explore and debate the 
long term orientation and evolution of epidemiology. The workshop was organized by the 
European Educational Programme in Epidemiology in collaboration with the International 
Epidemiological Association and European Young Epidemiologists group and counted on 
the participation of 14 early career epidemiologists from different European countries and 7 
experienced epidemiologists as discussants. This text does not intend to resuscitate a debate 
on the identity and role of epidemiology as a discipline, much less to offer a solution to 
these fundamental questions, but instead simply asks some questions about how 
epidemiology will respond to what we see as two major developments, as identified above - 
the inexorable rise of molecular biology and the shift from collectivist to individualist 
philosophy, which resonates with epidemiology's role as the basic science serving public 
health. 
2. Development of epidemiology and its role in research 
The importance of epidemiology as a scientific discipline has been steadily increasing over 
the past decades. In etiologic research this is partly driven by the intention to disentangle 
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the independent effects of risk factors for the predominant chronic diseases in Western 
civilizations, including cardiovascular diseases and cancer. These complex diseases are 
caused by many different factors, including genetic and non-genetic (diet, lifestyle, 
occupation, environment), where each factor is usually related to only small changes in risk. 
Consequently, the identification of risk factors usually requires the study of large samples 
with sophisticated analytic techniques, making this the prototype of epidemiologic research. 
Epidemiology has evolved into several different subdisciplines which are focused on 
specific areas of research, such as cardiovascular epidemiology, cancer epidemiology, 
genetic epidemiology, clinical epidemiology or nutritional epidemiology. What is 
noteworthy, though, is that the advancement of epidemiology often seems to be driven by 
developments in these other specific areas of research (and, equally important, by 
researchers in these other disciplines), rather than by epidemiology itself (or epidemiologists 
themselves). For example, the search for genetic variants that may be associated with 
increased health risk has led to the creation of large databases and to the conduct of genome 
wide association studies (GWAS). Partly because of the large number of variants examined, 
GWAS have a high risk of providing false-positive results. This has led to discussions and 
suggestions about how to conduct and interpret results of such studies in the fields of 
genetics and genetic epidemiology (Hattersley & McCarthy, 2005), although the question of 
how to appropriately deal with false-positive results is essentially a genuine general 
question in epidemiology. Another example comes from the field of clinical epidemiology, 
where a majority of pertinent studies are performed by clinicians, although the questions 
addressed in these studies are mostly those that traditionally fall in the field of 
epidemiology. 
One concern that applies to epidemiology as well as to other areas of scientific research is 
that advancements may in some instances simply be driven by the pure availability of new 
technologies or by advances in existing technology rather than by research questions 
pertinent to the area of research. An example is the development of various “-omics” 
technologies, which provides promising tools to allow large-scale biomarker studies, 
including discovery-oriented as well as hypothesis-testing investigations (Vineis & Perera, 
2007). However, there may also be an inherent risk, i.e. that the research agenda is dictated 
by the ability to have novel or advanced technologies instead of having sound scientific 
questions or hypotheses. Thus, epidemiology may be “vulnerable” to the focus on novel 
technologies by a tendency to “enrich” studies with these technologies in an attempt to 
obtain higher impact without critical reflections about their usefulness. Importantly, a fact 
that may be neglected is that the use of novel technologies is often vulnerable to similar 
shortcomings as are the more traditional approaches, and may even add complexity to the 
interpretation of results. For example, with regard to the use of biomarker technologies it 
was succinctly cautioned that “biochemical measures are almost always subject to the same 
problems of misclassification and bias [as answers provided by humans and their 
interviewers]” (Hunter, 1998). Also, it must be stressed that several of the major breakthroughs 
in epidemiology, including case-control and cohort studies that led to the discovery of the role 
of smoking as the major risk factor for lung cancer, serum cholesterol and smoking as risk 
factors for coronary heart disease and folate deficiency as a determinant of neural tube defects, 
in fact came from a rather “old-fashioned”, black box approach (Susser & Susser, 1996). 
Although it may seem self-evident, it is important to reiterate that the research agenda in 
epidemiology should be driven by questions that primarily address topics that fall within the 
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definition of epidemiology, rather than by technical details of related disciplines. Taking 
molecular epidemiology as an example, McMichael stated in an editorial more than 10 years 
ago, “…we do not need a new ‘molecular’ subdiscipline, with an inevitable inbuilt tendency to 
reductionism. Rather, we should critically incorporate the emerging array of molecular 
biologic measurements into mainstream epidemiologic research and thus broaden its scope. 
Good science will come from a synthesis that transcends disciplines and techniques” 
(McMichael, 1994). A successful example of the exploitation of genetic technology by 
epidemiologists to study exposures that are difficult to measure is Mendelian randomization, a 
method of direct value to understanding the environmental causes of common diseases using 
genetic variants as proxies (Davey Smith & Ebrahim, 2003). 
As indicated further in the next paragraphs, the future will probably bring the need to create 
and analyze even larger databases, implementing new technologies, and unraveling the 
complex interplay between environmental and genetic factors in disease etiology. What role 
will epidemiologists play in such endeavors? What is the relationship of epidemiology to 
other disciplines (genetics, clinical medicine, etc.) in the context of the creation and analysis 
of such databases? Will epidemiology be a method and will epidemiologists be the database 
managers? Or will epidemiology be a field that takes a leading role in shaping the research 
agenda? These are important questions which epidemiologists have to face for the future. 
By providing their specific expertise epidemiologists need to make sure that they form an 
essential part of that process. This means that they need to be integrated in all parts of 
research, including the formulation of hypotheses, development of study designs, 
establishment and conduction of studies, analysis and interpretation of data, and translation 
into public health settings. For this reason it is of course essential for epidemiologists to 
have detailed knowledge of their areas of interest. However, while the creation of 
subdisciplines is an enrichment of the field of epidemiology, it is important to keep in mind 
the global aim of epidemiology, that is, to study “the occurrence and distribution of health-
related states or events in specified populations, including the study of the determinants 
influencing such states, and the application of this knowledge to control the health 
problems”(Porta, 2008); nothing more, nothing less. 
3. The research agenda of an epidemiologist  
The question that we would like to address here is: ”What are the determinants of the choice 
of our area of research in epidemiology?”; in other words: “Based on which criteria do 
epidemiologists decide on which research to follow?”. Even when a researcher has a 
complete independent status, the choice is the result of several forces and not restricted to 
the appreciation of which are the best scientific questions. In addition to scientific curiosity 
and public health relevance, many other factors have an implicit or explicit role. 
Previous research experiences have great impact on our own research agenda. Changing 
one’s own specific area of research can be challenging, not only because of the need of new 
skills and knowledge but also because of the lack of national and international recognition 
and networking in the new research area, with consequent difficulties in being involved in 
collaborative research and having access to funding. Thus a change in area of research 
cannot be achieved in short time, while it needs long-term programming and a supportive 
research environment and infrastructure. 
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The research environment, the interaction with colleagues and their expertises and the 
facilities available at the research institute are obvious strong determinants of the research 
agenda.  
Facilities also include the availability of large databases, an issue that will be discussed in 
the next section. Here we emphasize that the availability of administrative large databases 
has increased dramatically the opportunities for epidemiological research. Sometimes, 
however, the availability of data may also shape the research questions. As opposed to 
already available databases, collection of new data can be specifically targeted at emerging 
research hypotheses, but it may be hampered by cost and organisational constraints. Often, 
we favour a research question that can be answered using already available data as opposed 
to a research question that needs time- and resource-intensive studies. This approach may 
allow the risk of testing hypotheses with lower a priori likelihood of providing a consistent 
answer that is reproduced in other studies, standing the test of time; these hypotheses 
would otherwise not be approached, at least not immediately, thus possibly creating 
opportunities for discovery (Vandenbroucke, 2008). It is difficult to know what combination 
of the two approaches, use of available data and new collections, maximizes the possibilities 
of progress in scientific knowledge.  
Hot topics are more likely to be published in more important journals, which, in turn, 
enhance the opportunities to reach the scientific community as well as lay people through 
the media. More important journals have also higher impact factor, that, although being 
criticized (Hernán, 2008), is still affecting researchers’ careers and access to funding. For 
their scientific and public health relevance as well for the reasons just described, hot topics 
are more likely to stimulate new research and to be considered as a research priority. This 
can translate in fast scientific progress and public health impact but, on the other hand, this 
process can divert resources and efforts from new developing fields.  
A new field can emerge only if funding agencies are giving it adequate support. Indeed, 
funding agencies have a central role in shaping the research agenda, and, therefore, the 
transparency of their selection process is a fundamental issue. However, even a transparent 
selection that is strictly based on quality, public health implications and scientific relevance 
of the submitted projects does not limit the influence of the agencies. Often, funding 
agencies open specific calls for research aiming at a priori decided objectives. We feel that the 
extent of the role of public and private funding agencies in shaping research agenda should 
be measured and monitored over time, including an assessment of the process that leads to 
the definition of the specific calls and the actual societal impact of funded projects. 
We started this section by considering an epidemiologist who has complete independence. 
The issue of independence has been studied and discussed in the epidemiological literature 
at length, mainly with reference to influences from the industry and, to a lesser extent, from 
governments (Pearce, 2008). Even assuming independence, however, we are aware of the 
fact that we all have a priori beliefs, we receive a salary from an institution or a funding 
agency, and we live in a community. It is widely accepted that epidemiologists should aim 
at giving priority to the research questions with the highest scientific interest and/or public 
health impact. This is however not a trivial task and we should recognise that the decision 
on what to study is affected by a large number of factors, many of which are not under our 
direct control.  
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4. Emerging opportunities and challenges in epidemiology: Large databases 
and use of secondary data 
The twenty-first century undoubtedly provides new horizons regarding the availability and 
use of data sources. In the last decade a growing number of public databases for depositing 
data have emerged. Much of the impetus for this growing trend was given by the paradigm 
shift we witnessed in genetic research, which has moved from a candidate gene approach 
focused on few genes to GWAS, which require multifaceted linked databases of larger 
populations (Ioannidis et al., 2006; Kaiser, 2002; Wylie & Mineau, 2003). Although less 
common, similar trends in data storing and sharing occurred in other areas of epidemiology 
as well. One example is the Pharmacogenomics Knowledge of Base of PharmGKB 
(www.pharmgkb.org) that was established to store, manage and make available molecular 
data in addition to phenotype data obtained from pharmacogenetic studies. In the field of 
classical epidemiology, multi-centric collaborative studies and pooled analyses are 
becoming more and more common. Moreover, systematic reviews and meta-analyses try to 
integrate and synthesize existing research studies in an attempt to derive new information 
by quantitative statistical analysis. By examining the totality of data available about an issue, 
systematic review can identify inconsistencies in existing data and point to areas of research 
needed, reduce the potential for erroneous findings occurring by chance, and more 
accurately define the benefit and possible adverse effects of management strategies.  
We feel that future epidemiological research will benefit greatly from the exchange of ideas 
between researchers and across disciplines/subdisciplines. This not only refers to concrete 
research results but also to approaches to the study of new areas. Existing studies could 
establish efficient routes of communication and co-ordination that allow a quick and 
detailed identification and promotion of common research areas. New studies could add 
protocols designed for specific purposes, preferably specialized rather than general, and 
study selected populations of special interest. A collaborative basis may in certain areas of 
research increase statistical power, ensure efficient design with large study populations, 
allow geographical comparisons and the replication of results, and give the possibility to 
study sub-groups or rare exposures (a crucial aspect of epidemiology) (Kogevinas et al., 
2004). 
Questions about ownership, custody and rights of access to data are major issues and 
determine restrictions to data sharing and collaborative research. These questions focus 
mainly on protection of privacy (the ability to control information about oneself) and 
confidentiality (the obligation of a second party to not reveal private information about an 
individual to a third party without the permission of the person concerned) (Willison, 1998). 
Confidentiality and privacy issues are emerging limiting factors (for both new data 
collection and use of available databases) that can have important effects on shaping 
research agenda and public health surveillance (Cuttini et al., 2009). At present, in many 
countries, legislations on confidentiality are defined with little consideration on their impact 
on medical and public health research, thus favouring personal privacy above societal 
benefits. The four principles of protection of a research participant are autonomy (self-
determination), beneficence (maximal benefit), nonmalfeasance (minimal harm), and justice 
(distribution of benefits and harms across groups in society) (National Commission for 
Protection of Human Subjects of Biomedical and Behavioral Research, 1979). Although these 
principles focused on experimental studies in the past, it is essential that we follow 
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established ethical guidelines also in observational studies that are perceived to have 
minimal harm. In the past, these issues have primarily been raised with regard to clinical 
trials where the intervention itself may do harm to the research subject. In observational 
studies, however, the concern about harm is not so much about the fact that the study 
procedures may do harm to the research subject (which is usually minimal because of the 
observational nature) but more about the fact that the results of that research may 
(indirectly) harm the participants or a group thereof. For example, results of a genetic study 
may reveal that individuals with a certain genetic variation may have a higher risk of 
disease. Should researchers report these results to their study subjects? If yes, then such 
reporting could harm the self-determination of these subjects because they may not have 
asked for that specific test. If not, then the researcher may withhold important information 
from that person. If results with potential clinical significance are delivered to individual 
participants, the communication should be made in close collaboration with clinicians who 
should be part of the research group from the beginning of the project. In addition, if 
researchers decide to disclose the results, participants should have the opportunity at the 
time of enrolment to give their consent to receive information about incidental findings or 
not, and should receive explanations on how incidental information will be handled. Often 
these two requirements are not met or are unfeasible in a specific research project. Partly 
based on these concerns, some countries already adopted new laws or regulations, such as 
the Genetic Information Nondiscrimination Act in the United States in the year 2008 
(Hudson et al., 2008). 
As large electronic databases have been developed, several management models have been 
designed [e.g., the RGE (Resource for Genetic and Epidemiological Research) model, the 
Sweeney’s model, the deCODE Genetics model and others] focusing on confidentiality 
versus research use, as well as public versus private access (Wylie & Mineau, 2003). 
Individual rights of subjects must be respected at all times, but should not be misused by 
data collecting institutions as an argument to restrict access of other researchers. A balance 
between individual rights to privacy and the societal benefit of research must be established 
(Bergmann et al., 2008). 
Another important issue when examining large databases is the frequent lack of explicit 
reports on the methods followed for the collection of the data from different sources, the 
completeness of this information, and a discussion of limitations of the data source. This 
may also be driven by the strict space limits of most journals as investigators may have had 
appropriately described everything in the methods section but word count limitations led to 
the deletion of this information. There are examples of large collaborative studies where all 
the methods and quality have been specified and assured (Tunstall Pedoe, 2003). There is a 
crucial need for researchers and journal editors to become aware that guidelines have been 
developed on how to conduct and how to report results of epidemiologic studies 
(International Epidemiological Association, 2007; von Elm et al., 2007). 
The next step will be to enhance the availability of methods for easily depositing data and to 
provide tools for ensuring the sustainability of the databases. Large databases may benefit 
from widely available electronic search tools listing available studies on a specific topic and 
they should encompass both published and deposited data. A research environment that 
promotes and rewards by publishing only results that reach statistical significance is likely 
to foster data dredging and will create a distorted literature with very low credibility 
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(Easterbrook et al., 1991; Ioannidis, 2005). The scientific community will also have to discuss 
issues of authorship, data property, and funding of secondary analyses. 
The study of demographic, genetic, medical and environmental data from different 
populations may create an exciting and promising approach to identify the causes of 
common diseases and create effective preventive measures. “If you have large, accurate data 
sets on the health and death of human beings, what else do you need to improve the health 
of the public other than sound scientific method, cautious inference and a dialogue between 
science and policy?” (Coleman, 2007). Our knowledge of health and disease will certainly be 
greatly enhanced when the use of this immense amount of information is made available 
through the application of solid epidemiological principles. We are aware that there are 
problems to solve and agreements to reach within the field of large databases and use of 
secondary data. In addition, large databases and secondary analyses may not be useful to 
answer all new research questions, but they may be a (powerful) tool for epidemiological 
research. 
5. Epidemiology and society: How each influences the other  
Epidemiology tells us what we want to know about the human condition and, often, how it 
might be improved, in a way which no other science can offer (Coleman, 2007). This is a 
great challenge and a major reason why we find it so attractive and intellectually rewarding.  
Throughout history, society has conditioned and channelled science. Societal reaction also 
influences the translation of epidemiology into public health. Many of the 20th century 
beliefs regarding the relation between epidemiology and society turned out to be only half-
truths: 1) epidemiology would lead to prevention, 2) prevention was better than cure, 3) 
social justice would be achieved through prevention and 4) epidemiology would pervade 
clinical medicine and change its practice. We now recognize that success in epidemiology 
has not necessarily implied public health achievements (e.g. evidence on tobacco vs. 
economic interests) and health inequalities tend to increase instead of decrease. 
The present loss of credibility before the society (and other fields of science) regarding risk 
factor epidemiology is partly a consequence of a reductionist view, i.e., a focus on 
associations between a single exposure and a single outcome, which frequently originates 
inconsistent messages (the same exposure may be publicized either as risk or protective 
factor on different adverse outcomes). Also, conflicting results regarding the same 
association might raise the question of how much evidence is needed to intervene or to 
advocate intervention (Taubes, 1995). Publication of small amounts of information without 
considering implications contributes to incomplete knowledge and in our view reflects some 
degree of irresponsibility. Publication drive may result in objective dishonesty that must be 
fought against. Introspection should be carried out before publication: are we honestly 
convinced by our findings? 
Etiological epidemiology has mostly been looking at individual susceptibility and the 
distribution of disease in the population has been undervalued. The growing emphasis on 
genetic/molecular research contributes to direct epidemiology towards individual-based 
prevention as opposed to population level approaches. Concern with individual 
susceptibility has neglected the distribution of disease in the population, leading to the 
“type III error” – a good study to answer the wrong question. While an increased interplay 
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between biotechnology, infrastructures and methods may be the future of epidemiologic 
research, translational research must be promoted, starting from the population and 
responding to its needs, with special attention being required towards understudied groups 
(e.g. migrants). 
Political stability is an important basis for public health. Inequalities in health and research 
between countries, even within Europe, emphasize the need for a) one epidemiology for all 
societies in the 21st century, b) more quality research from less rich countries, c) stronger 
political will to translate evidence into action.  
The reinforcement of epidemiologists’ professional image with society in general is needed. 
The importance given to individual values such as the right to privacy has risen barriers to 
research that in our view do not benefit society as a whole while in fact the risk of disrespect 
for individual rights is smaller than its theoretical maximum. There is the need to 
distinguish between the risk to personal autonomy from the use of identifiable data without 
consent to select a given individual for prurient interest or unauthorized disclosure (moving 
from population data to the individual) and the far smaller risk posed by aggregating 
individual data for research in order to draw general conclusions about society (from 
individual data to the population) (Coleman, 2007). Striking the right balance between the 
confidentiality of identifiable health data and the need for medical research to improve 
public health is now an issue in many countries (Coleman et al., 2003). Though it is not 
necessarily straightforward where the line should be drawn, the societal pendulum needs to 
swing back towards the collective responsibility for medical research and public health 
surveillance. Current regulatory climate risks to refrain the scientific community from using 
available data to control health problems and improve population health. 
We feel the need for a strengthening of the link between epidemiologic research and society, 
in order to translate findings into the effective improvement of population health. Part of 
this process should be the reinforcement of epidemiologists’ professional image in the 
society in general to win its trust. 
6. Conclusion 
Research has been strongly influenced by a random and passive intersection between 
biotechnology, infrastructures and available methods. Young epidemiologists must 
reinforce their knowledge on the substantive issues they are researching and promote an 
active interaction between biology and society. Translational research is needed to use 
relevant laboratory research resources in population-based studies and to make the results 
of epidemiological studies useful to an individualized and predictive medical practice. 
Professionals need to be prepared to collate data. Questions about ownership, custody and 
rights of access to data are major and determine restrictions to research. Individual rights of 
subjects must be respected at all times, but should not be misused by institutions that 
collected data as an argument to restrict access of other researchers. More than new 
information, we need to use the information we already have. A balance between individual 
rights to privacy and the societal benefit of research must be encountered. 
In order to gain the possibility of playing a more active role in their research agenda, 
epidemiologists must improve their communication skills, both regarding risk 
www.intechopen.com
 
Epidemiology – Current Perspectives on Research and Practice 
 
10
communication to the population and scientific dialogue with other researchers and 
clinicians. Also, they need to conquer a position in funding agencies and as consultants for 
policy makers, and be available for these tasks over time. 
The need to reinforce the professional image of epidemiologists could be met by as good a 
formal education as possible along with good epidemiologic practices. Epidemiological 
expertise will continue to be required for the attempt to set rational priorities for the control 
of disease and health promotion. This challenge is as breathtaking as we need to keep us on 
track to contribute to design the future of epidemiology. 
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